Monogenic Diabetes
Gene: CTLA4ClinGen DEFINITIVE (Dec'2020)
https://search.clinicalgenome.org/CCID:004595
A systematic review of published reports by Jamee, et al (PMID: 33788257), found that 23/222 CTLA4 haploinsufficiency cases (10.8%) were reported to have insulin-dependent diabetes mellitus.Created: 5 Feb 2026, 3:46 p.m. | Last Modified: 5 Feb 2026, 3:46 p.m.
Panel Version: 0.192
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, MONDO:0014493
Publications
Well reported for autoimmune lymphoproliferative syndrome, type VCreated: 2 Nov 2020, 3:39 p.m. | Last Modified: 2 Nov 2020, 3:39 p.m.
Panel Version: 0.5244
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Phenotypes
Autoimmune lymphoproliferative syndrome, type V (MIM#616100), AD
Gene: ctla4 has been classified as Green List (High Evidence).
gene: CTLA4 was added gene: CTLA4 was added to Monogenic Diabetes. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: CTLA4 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: CTLA4 were set to Autoimmune lymphoproliferative syndrome, type V (MIM#616100), AD